Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dalteparin Sodium Injection

Approval Number

国药准字H20201000

Company南京健友生化制药股份有限公司

Registration Date

May 26, 2020

Previous Approval Numbers

国药准字H20153024

Drug Information

Generic Name

达肝素钠注射液

Dosage Form

注射剂

Strength

0.3ml:7500AⅩaIU

Drug Type

化学药品

Registration Date

May 26, 2020

Company Information

Applicant Company

Company Name南京健友生化制药股份有限公司

Company Address

南京高新开发区MA010-1号地

Manufacturing Company

Company Name南京健友生化制药股份有限公司

Company Address

南京高新技术产业开发区学府路16号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy